Concepedia

651O Pembrolizumab (pembro) + carboplatin (carbo) + paclitaxel (pacli) as first-line (1L) therapy in recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Phase VI KEYNOTE-B10 study

M.R. Dzienis, J.E. Cundom, Christian Sebastian Fuentes, A.R. Hansen, M.J. Nordlinger, A.V. Pastor, P. Oppelt, A. Neki, R.W. Gregg, I.P. Figueiredo Lima,

Annals of Oncology · 2022 · 21 citations · 0 references

Concepts

MedicineOncologyPharmacologyCancer PharmacologyChemotherapyMetastasisCancer ImmunotherapyMalignant NeoplasmsMalignant TumorsMetastatic Cancer ManagementMetastatic Disease TreatmentSquamous Cell CarcinomaMetastatic Squamous Cell CarcinomaMetastatic Tumors To The HeadMetastatic Tumors To The NeckPembrolizumab TherapyPlatinum-based Regimens